Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 2/12/2020
SIETES contiene 93176 citas

 
 
<< anterior 21 a 40 de 182 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Califf RM, McCall J, Harrington RA. Assessing research results in the medical literature: trust but verify. JAMA Intern Med 2013;173:1053-5. [Ref.ID 95719]
22. Cita con resumen
Avorn J. Healing the overwhelmed physician. N Y Times (Print) 2013:11 de junio. [Ref.ID 95635]
23. Cita con resumen
Toussaint B. EU clinical trial regulation. Lancet 2013;381:1719-20. [Ref.ID 95444]
24.Tiene citas relacionadas
Ioannidis JPA. Mega-randomized clinical trials for blockbuster drugs - Reply. JAMA 2013;309:1682-3. [Ref.ID 95285]
25.Tiene citas relacionadas Cita con resumen
Landy DC, Hecht EM. Mega-randomized clinical trials for blockbuster drugs. JAMA 2013;309:1682-3. [Ref.ID 95284]
26. Cita con resumen
Krumholz HM, Jackevicius CA, Ross JS. Tamiflu: 14 flu seasons and still questions. BMJ 2013;346:9. [Ref.ID 94927]
27.Tiene citas relacionadas Cita con resumen
Ioannidis JPA. Mega-trials for blockbusters. JAMA 2013;309:239-40. [Ref.ID 94781]
28. Cita con resumen
Gotzsche P. Deficiencies in proposed new EU regulation of clinical trials. BMJ 2013;346:21-3. [Ref.ID 94761]
29. Cita con resumen
Chalmers I, Glasziou P, Godlee F. All trials must be registered and the results published. BMJ 2013;346:8. [Ref.ID 94757]
31. Cita con resumen
Webster PC. Canada clamps down on access to drug safety data. Lancet 2012;380:1805-6. [Ref.ID 94120]
32. Cita con resumen
Braillon A, Bewley S, Herxheimer A, Mansfield P, Lexchin J, Menkes DB, Ziganshina LE, Montastruc J-L. Marketing versus evidence-based medicine. Lancet 2012;380:340. [Ref.ID 93515]
33. Cita con resumen
Anónimo. The future of independent drug bulletins. Drug Ther Bull 2012;50:61. [Ref.ID 93107]
34. Cita con resumen
Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni V. Vaccines for preventing influenza in healthy children Updated. Cochrane Database of Systematic Reviews 2012:15 de agosto. [Ref.ID 92910]
35.Tiene citas relacionadas
Dickersin K, Rennie D. The evolution of trial registries and their use to assess the clinical trial enterprise. JAMA 2012;307:1861-4. [Ref.ID 92858]
36.Tiene citas relacionadas Cita con resumen
Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in clinicalTrials.gov, 2007-2010. JAMA 2012;307:1838-47. [Ref.ID 92856]
37. Cita con resumen
Anónimo. Recherche clinique sous influence: penser les alternatives. Prescrire 2012;32:311-4. [Ref.ID 92580]
38.Tiene citas relacionadas Cita con resumen
Ross JS, Tse T, Zarín DA, Xu H, Zhou L, Krumholz HM. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ 2012;344:14. [Ref.ID 92178]
39. Cita con resumen
40. Cita con resumen
Olesen F. Putting research into primary care practice. BMJ 2011;343:650-1. [Ref.ID 91720]
Seleccionar todas
 
<< anterior 21 a 40 de 182 siguiente >>